Medicare Coverage for Neuropathy Medications

Published by admin On February 2, 2026

Check the TRICARE Formulary to see if you need prior authorization. According to IQVIA, pregabalin capsules generated around $5.4bn in annual sales in the US for the 12 month period ending 31 May 2019. Below is information you may want to consider if you have insurance and receive pregabalin.

Setting and data

From this dataset we extracted data on all prescriptions dispensed between April 2013 and July 2016 for pregabalin capsules of any form.
The price may also increase for higher strengths of the drug.
If pregabalin had come entirely off patent in September 2015, and Pfizer had not appealed, we estimate the NHS would have spent £502 million less on pregabalin to July 2017.
While side effects like drowsiness and dizziness are common at first, they typically improve as your body adjusts.

The Medicare lyrica price per pill Plan Finder is the most reliable tool for comparing plans. By entering a list of current medications and preferred pharmacies, patients can see realistic annual cost projections. Step therapy requires patients to try lower-cost or first-line medications before higher-cost drugs are approved.

What process do generics go through for approval?

The separate legal dispute over the legitimacy of the neuropathic pain patent itself poses a final challenge. Legal decisions—and a corporate body’s right to follow due process through the court, Court of Appeal and ultimately to the Supreme Court—can have large cost implications for the NHS. Our model shows that the NHS would have spent £502 million less on pregabalin between October 2015 and July 2017, if the patent ruling had not been challenged by Pfizer. This equates to approximately 3.25% of the total NHS England primary care prescribing spend for that period. If Pfizer is unsuccessful in their final appeal, the NHS would be well served by seeking to retrieve these excess costs. We included only practices that had a Clinical Commissioning Group (CCG) code and had at least 1000 patients on list to ensure we excluded prescribing in non-standard settings such as prisons or homeless services.